Applied BioCode (TPE:6598) Institutional Ownership: 0.04% (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6598 Applied BioCode Corp TPE:6598
74 GF Score
Price NT$30.10
GF Value NT$23.35
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Applied BioCode Institutional Ownership?

Applied BioCode TPE:6598 +4.70% 74 Institutional Ownership is 0.04% as of Aug. 01, 2026. GuruFocus rates TPE:6598 with a GF Score™ of 74/100 and a GF Value™ of NT$23.35 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Applied BioCode's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Applied BioCode's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Applied BioCode's Float Percentage Of Total Shares Outstanding is 0.00%.

Applied BioCode Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Applied BioCode's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied BioCode Institutional Ownership Chart

Applied BioCode Historical Data

The historical data trend for Applied BioCode can be seen below:

2022-11-30 2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31
Institutional Ownership 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04
TPE:6598
74GF Score
Applied BioCode Corp TPE:6598
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied BioCode Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.04% mean?
Applied BioCode (TPE:6598) has a Institutional Ownership of 0.04% as of Aug. 01, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Applied BioCode and its competitors.
Is Applied BioCode's Institutional Ownership too high?
Applied BioCode's current Institutional Ownership is 0.04%. Overall, Applied BioCode has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Applied BioCode's Institutional Ownership compare to ABT and SYK?
Applied BioCode's Institutional Ownership of 0.04% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Applied BioCode and its competitors. Applied BioCode's current Institutional Ownership is 0.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied BioCode stock overvalued right now?
Based on GuruFocus' analysis, Applied BioCode (TPE:6598) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$23.35, compared to a current price of NT$30.10 — trading 28.9% above its estimated fair value. The current Institutional Ownership is 0.04%. Applied BioCode's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Applied BioCode (TPE:6598), the current Institutional Ownership is 0.04% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Applied BioCode (TPE:6598) Overvalued in 2026?

Based on GuruFocus' analysis, Applied BioCode stock appears to be overvalued. The current stock price of NT$30.10 is trading 28.9% above its estimated GF Value™ of NT$23.35. GuruFocus considers Applied BioCode to be Modestly Overvalued.

Key valuation signals for TPE:6598:

  • Institutional Ownership: 0.04%
  • GF Value™: NT$23.35 vs. price of NT$30.10 (28.9% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Applied BioCode Business Description

Address 12130 Mora Dr., Unit 2, Santa Fe Springs, CA, USA, 90670
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
74GF Score

Get the complete analysis for TPE:6598

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.10
Price
NT$23.35
GF Value